European Journal of Immunology · 2008 · 95 citations · 44 references
Life SciencesImmunologyNeurologyAutoimmunityMonoclonal AntibodiesNeuroimmunologyAutoimmune Neurological DisordersCerebrospinal Fluid ImmunologyDemyelinating DiseasesHumoral ImmunityMultiple SclerosisNeuroinflammationAntibodiesCerebrospinal Fluid SystemMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis ImmunopathologyMultiple Sclerosis PathologyMyelin Antigen TargetsMyelin AntigensWhite Matter Pathology
Clonally expanded plasma cells (cePC) and their presumed products, oligoclonal immunoglobulin G bands (OCB), are characteristic findings in the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS). While cePC and OCB strongly suggest an involvement of B cell-dependent immune mechanisms in the pathogenesis of MS, their actual pathological relevance and target antigens remain unknown. To further understand the potential role played by cePC, we generated a panel of monoclonal antibodies (MS-mAb) from CSF-derived cePC from four patients with early or definite MS. Single-cell RT-PCR of correctly paired heavy and light chain immunoglobulin genes from individual cePC ensured the subsequent resurrection of their original antigen specificity. Immunofluorescence stainings of MS lesion tissue with MS-mAb revealed myelin reactivity in the cePC repertoire of all four patients and intracellular filament reactivity in one patient. While myelin staining by MS-mAb was only rarely detectable in non-MS CNS white matter tissue, it was greatly enhanced at the edge of demyelinating lesions in MS brain tissue. Our findings provide conclusive evidence for the presence of an antigen-driven B cell response in the CSF of MS patients directed against epitopes present in areas of myelin degradation.
44
Predominant Autoantibody Production by Early Human B Cell Precursors
Hedda Wardemann, Sergey Yurasov, Anne Schaefer et al. · Science · 2003 · 2.1K citations
Identification of autoantibodies associated with myelin damage in multiple sclerosis
Claude P. Genain, Barbara Cannella, Stephen L. Hauser et al. · Nature Medicine · 1999 · 890 citations
Life Sciences, Immunology, Neurology +14